STOCK TITAN

Milestone Scientific, Inc. - $MLSS STOCK NEWS

Welcome to our dedicated page for Milestone Scientific news (Ticker: $MLSS), a resource for investors and traders seeking the latest updates and insights on Milestone Scientific stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Milestone Scientific's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Milestone Scientific's position in the market.

Rhea-AI Summary
Milestone Scientific Inc. (NYSE:MLSS) has commenced commercial sales of CompuFlo® disposables for use in neurostimulation spinal cord stimulator implantation procedures at the University of Texas Medical Branch (UTMB) Health Clear Lake Campus Hospital, following a successful evaluation process by Dr. Patrick Karas, MD, with 100% success rate and no complications. This expansion of use within the institution showcases the potential of CompuFlo® in improving patient outcomes and lowering costs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.13%
Tags
none
-
Rhea-AI Summary
Milestone Scientific Inc. (MLSS) has entered into an agreement with Bioline Supply to distribute the CompuFlo® Epidural System and related disposables in Spain. This partnership aims to provide pain clinics and hospitals in Spain with access to Milestone Scientific's innovative technology, enhancing the safety and predictability of epidural procedures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.16%
Tags
none
-
Rhea-AI Summary
Milestone Scientific Inc. (NYSE: MLSS) reports a 45% increase in domestic sales for the third quarter of 2023, along with a new online store, higher gross profit margin, and expansion in the medical division. The company also made progress in advancing the reimbursement strategy for the CompuFlo® Epidural System.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Milestone Scientific Inc. (NYSE:MLSS) to host conference call to discuss Q3 financial results and corporate progress, accessible via phone and webcast
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.11%
Tags
-
Rhea-AI Summary
Milestone Scientific Inc. (NYSE:MLSS) has started selling CompuFlo® Epidural disposables to Island Ambulatory Surgery Center, affiliated with Mount Sinai Health System, marking the company's entry into the ambulatory surgery center market. The founder and medical director, Dr. Leon Reyfman, reported 100% success in the evaluation of the system, praising its potential to transform drug delivery in pain management and anesthesiology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.41%
Tags
none
-
Rhea-AI Summary
Milestone Scientific appoints Dr. Didier Demesmin to Board of Directors, expects CompuFlo Epidural System to become standard of care in epidural analgesia.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
management
Rhea-AI Summary
Milestone Scientific Inc. reports a 77% increase in revenue for the second quarter of 2023, reaching $2.9 million. Gross profit also increased by 178% compared to the same period last year. The company attributes this growth to the success of their new online store, which has improved margins and provided a closer relationship with customers. The medical division has received positive reimbursement from commercial payers for patients involved in motor vehicle accidents, validating their technology and reimbursement strategy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.82%
Tags
none
-
Rhea-AI Summary
Milestone Scientific Inc. (MLSS) will host a conference call on August 15, 2023, to discuss its financial results for the second quarter of 2023 and corporate progress. The call will be available via telephone and webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.53%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.76%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.55%
Tags
conferences
Milestone Scientific, Inc.

NYSE:MLSS

MLSS Rankings

MLSS Stock Data

53.32M
50.52M
14.41%
5.7%
0.52%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
LIVINGSTON

About MLSS

milestone scientific has developed and currently manufactures, markets and sells “computer-controlled local anesthetic delivery” (c-clad) systems for the improved and painless delivery of local anesthetic. the system is marketed in dentistry under the trademarks compudent & sta system (newest technology). sta™ system is suitable for all dental procedures. compudent™ and the more advanced sta™ system are suitable for all dental injections regularly used in plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, orthopedics and a number of other disciplines. compudent and the sta system is sold in the united states and worldwide in over 25 countries.